Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pravibismane - Microbion Corporation

Next Previous
X
Search
Drug Profile

Pravibismane - Microbion Corporation

Alternative Names: BisEDT Antimicrobial Gel; MBN-101

Latest Information Update: 02 Feb 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Microbion Corporation
  • Class Alkanes; Anti-infectives; Antibacterials; Foot disorder therapies; Organic sulfur compounds; Skin disorder therapies
  • Mechanism of Action Bacterial biofilm inhibitors; Bacterial growth inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Cystic fibrosis-associated respiratory tract infections; Nontuberculous mycobacterium infections
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Bacterial infections; Diabetic foot ulcer
  • Phase I Cystic fibrosis-associated respiratory tract infections; Nontuberculous mycobacterium infections

Most Recent Events

  • 30 Jan 2024 Pravibismane - Microbion Corporation receives Orphan Drug status for Nontuberculous mycobacterium infections in USA
  • 30 Jan 2024 Antimicrobial data from a preclinical trial in Nontuberculous mycobacterial infections released by Microbion Corporation
  • 30 Jan 2024 Microbion Corporation plans a phase I trial for Nontuberculous mycobacterium infections (Inhalation)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top